Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
– Using Invitae’s Ciitizen patient-driven data platform, AstraZeneca and the Cholangiocarcinoma Foundation will access lived experience of patients with a rare cancer to drive further research – – Real-world insights will be translated into cholangiocarcinoma treatment patterns and outcomes in a rapidly evolving disease landscape – SAN FRANCISCO, Oct. 27, 2022 /PRNewswire/…